Recently, it has been demonstrated that ΔNp63α transactivates RSK4 to promote CSCs properties and radioresistance in ESCC through direct phosphorylation of GSK-3β at Ser9, consequently activating of the β-catenin signaling pathway [32]. This evidence concerns the gene RPS6KA6 and esophageal squamous cell carcinoma.